Published in
Elsevier, European Journal of Cancer, (86), p. 240-247, 2017
DOI: 10.1016/j.ejca.2017.09.009
Links
Tools
First-in-man phase I study assessing the safety and pharmacokinetics of a 1-hour intravenous infusion of the doxorubicin prodrug DTS-201 every 3 weeks in patients with advanced or metastatic solid tumours
Journal article published in 2017 by
Patrick Schöffski 
,
Jean-Pierre Delord,
Etienne Brain ,
Jacques Robert,
Herlinde Dumez,
Jamal Gasmi,
André Trouet
,
Jean-Pierre Delord,
Etienne Brain ,
Jacques Robert,
Herlinde Dumez,
Jamal Gasmi,
André Trouet
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 